0000001 001  NULL    **6;0;START              
0000001 002  -----   -----                    
0000002 010  FU      WASHINGTON/NEW           Z99 
0000002 020  NP1     YORK                     Z2 Z1mf 
0000002 021  (       (                        
0000002 030  NP1     Reuters                  Z3c 
0000002 031  )       )                        
0000002 032  -       -                        
0000002 040  AT      The                      Z5 
0000002 050  NP1     U.S.                     Z1mf[i1.2.1 Z3c[i1.2.1 
0000002 060  NN1     Treasury                 Z1mf[i1.2.2 Z3c[i1.2.2 Z3c 
0000002 070  NN1     Department               H2/S5+c X2.2 
0000002 080  VVD     took                     A9+ T1.3 C1 A1.1.1 M2 A2.1+ X2.4 P1 M1 X2.5+ F1@ F2@ Q1.2@ B3@ 
0000002 090  JJ      new                      T3- 
0000002 100  NN2     steps                    M1 T1.2 H5 A1.1.1 K1@ 
0000002 110  II      on                       Z5 
0000002 120  NPD1    Monday                   T1.3 
0000002 130  TO      to                       Z5 
0000002 140  VVI     curb                     A1.7+ 
0000002 150  JJ      tax-avoiding             Z99 
0000002 160  JJ      corporate                S5+ I2.1/S5+ 
0000002 161  NULL    <quote>                  
0000002 162  -----   -----                    
0000002 170  NN2     inversions               A6.1- 
0000002 171  ,       ,                        
0000002 172  NULL    </quote>                 
0000002 173  -----   -----                    
0000002 180  IW      with                     Z5 
0000002 190  AT      the                      Z5 
0000002 200  JJ      pending                  T1.1.3 
0000002 210  NNU     $160                     I1.2/Z99[i2.2.1 
0000002 220  NNO     billion                  I1.2/Z99[i2.2.2 N1 I1 
0000002 230  NN1     merger                   S5+ 
0000002 240  IO      of                       Z5 
0000002 250  NP1     Pfizer                   Z99 
0000002 260  JJ      Inc                      I2.1 
0000002 270  CC      and                      Z5 
0000002 280  NP1     Allergan                 Z3[i3.2.1 
0000002 290  NN1     Plc                      Z3[i3.2.2 I2.1/S5+ 
0000002 300  VVN     seen                     X3.4 X2.1 S1.1.1 X2.5+ A7+ 
0000002 310  II      as                       Z5 
0000002 320  AT1     a                        Z5 
0000002 330  JJ      potential                A7+ 
0000002 340  NN1     casualty                 B2-/S2mf B3 A1.4/S2mf 
0000002 341  .       .                        
0000003 001  -----   -----                    
0000004 010  NN1     Treasury                 G1.1/I1.1c 
0000004 020  NN1     Secretary                I3.2/S2mf S7.1+/S2mf 
0000004 030  NP1     Jack                     Z1mf[i4.2.1 Z3c[i4.2.1 Z1m 
0000004 040  NP1     Lew                      Z1mf[i4.2.2 Z3c[i4.2.2 
0000004 050  VVZ     testifies                G2.1 A5.2+ 
0000004 060  II      at                       Z5 
0000004 070  AT1     a                        Z5 
0000004 080  NN1     Senate                   S7.1+ 
0000004 090  NN2     Appropriations           A9+ 
0000004 100  NN1     Subcommittee             S7.1+/S5+c 
0000004 110  VVG     hearing                  X3.2 X2.3+ G2.1@ 
0000004 120  II      on                       Z5 
0000004 130  AT      the                      Z5 
0000004 140  FO      FY2017                   Z99 
0000004 150  NN1     budget                   I1 G1.1/I1 I1.3- 
0000004 160  IF      for                      Z5 
0000004 170  AT      the                      Z5 
0000004 180  NN1     Treasury                 Z3c 
0000004 190  NN1     Department               H2/S5+c X2.2 
0000004 200  II      on                       Z5 
0000004 210  NP1     Capitol                  Z1mf[i6.2.1 Z3c[i6.2.1 Z2 Z2[i5.2.1 Z3c[i5.2.1 
0000004 220  NP1     Hill                     Z2[i8.3.1 Z2[i7.3.1 Z1mf[i6.2.2 Z3c[i6.2.2 Z2[i5.2.2 Z3c[i5.2.2 
0000004 230  II      in                       Z2[i8.3.2 Z2[i7.3.2 Z5 
0000004 240  NP1     Washington               Z2[i8.3.3 Z2[i7.3.3 Z2 Z1mf 
0000004 250  NPM1    March                    T1.3[i9.2.1 T1.3 
0000004 260  MC      8                        T1.3[i9.2.2 N1 T1.2 T3 T1.3 N3.2 
0000004 261  ,       ,                        
0000004 270  MC      2016                     N1 T1.2 T3 T1.3 N3.2 
0000004 271  .       .                        
0000004 272  -----   -----                    
0000004 280  NP1     REUTERS/Joshua           Z1mf[i10.2.1 Z3c[i10.2.1 
0000004 290  NP1     Roberts                  Z1mf[i10.2.2 Z3c[i10.2.2 Z1mf 
0000006 010  AT      The                      Z5 
0000006 020  NN2     changes                  A2.1+ I1 B1 
0000006 021  ,       ,                        
0000006 030  RRR     less                     A13.6 
0000006 040  CSN     than                     Z5 
0000006 050  AT1     a                        Z5 
0000006 060  NNT1    year                     T1.3 P1c 
0000006 070  CS      before                   Z5 
0000006 080  NNB     President                G1.1/S7.1+/S2mf 
0000006 090  NP1     Barack                   Z1mf[i11.2.1 Z3c[i11.2.1 
0000006 100  NP1     Obama                    Z1mf[i11.2.2 Z3c[i11.2.2 
0000006 110  VVZ     ends                     T2- 
0000006 120  APPGE   his                      Z8m 
0000006 130  NN1     term                     Q3 T1.3 S6+ 
0000006 131  ,       ,                        
0000006 140  VV0     follow                   M1 N4 S7.1- X2.4 X2.5+ A6.1+ A1.1.1 A2.2 K5.1 X3.4 
0000006 150  JJ      sharp                    O4.4 A10+ X9.1+ X5.1+ N3.8+ B2- X3.1 E3- A5.3+ A5.1+ T4 
0000006 160  JJ      political                G1.2 
0000006 170  NN1     criticism                Q2.2/E2- X2.4 
0000006 180  IO      of                       Z5 
0000006 190  NP1     Pfizer                   Z99 
0000006 191  GE      's                       Z5 
0000006 200  CC      and                      Z5 
0000006 210  NP1     Allergan                 Z99 
0000006 211  GE      's                       Z5 
0000006 220  NN1     merger                   S5+ 
0000006 221  ,       ,                        
0000006 230  DDQ     which                    Z8 Z5 
0000006 240  VM      would                    A7+ 
0000006 250  VBI     be                       A3+ Z5 
0000006 260  AT      the                      Z5 
0000006 270  JJT     largest                  N3.2+++ N5+++ A11.1+++ 
0000006 280  NN1     inversion                A6.1- 
0000006 290  NN1     deal                     N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000006 300  RR      ever                     T1.1 N6+++ A13 
0000006 301  .       .                        
0000006 302  -----   -----                    
0000006 310  CS      While                    Z5 
0000006 320  AT      the                      Z5 
0000006 330  NN2     rules                    G2.1 X4.2 A6.2+ Q3 
0000006 340  VDD     did                      A1.1.1 G2.2- X9.2+ E3- G2.1% Z5 
0000006 350  XX      not                      Z6 
0000006 360  JJ      single                   N5--- S5- S3.2- M3 
0000006 370  RP      out                      M6 
0000006 380  DD1     this                     M6 Z5 Z8 
0000006 390  NN1     deal                     N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000006 391  ,       ,                        
0000006 400  MC1     one                      N1 T3 T1.2 
0000006 410  IO      of                       Z5 
0000006 420  AT      the                      Z5 
0000006 430  NN2     provisions               O2 G2.1 
0000006 440  VVZ     takes                    A9+ T1.3 C1 A1.1.1 M2 S7.1- A2.1+ X2.4 S6+ S7.4+ N3 P1 M1 X2.5+ F1@ F2@ Q1.2@ B3@ 
0000006 450  NN1     aim                      X7+ M6 
0000006 460  RR      directly                 M6 N3.8+ S1.1.1 
0000006 470  II      at                       A1.1.1[i12.2.1 Z5 
0000006 480  PPH1    it                       A1.1.1[i12.2.2 Z8 
0000006 481  .       .                        
0000007 001  -----   -----                    
0000008 010  NN2     Shares                   N5.1- I1.1 
0000008 020  IO      of                       Z5 
0000008 030  JJ      Dublin-based             Z99 
0000008 040  NP1     Allergan                 Z99 
0000008 050  VVD     fell                     M1 N5-/A2.1 S7.1- L1- A1.8+ G2.2- X9.2- K5.2 
0000008 060  MC      22                       N5[i13.2.1 N1 T1.2 T3 T1.3 N3.2 
0000008 070  NNU     percent                  N5[i13.2.2 N5 
0000008 080  II      in                       Z5 
0000008 090  JJ      after-market             Z99 
0000008 100  NN1     trading                  I2.2 
0000008 101  ,       ,                        
0000008 110  CS      while                    Z5 
0000008 120  NN2     shares                   N5.1- I1.1 
0000008 130  IO      of                       Z5 
0000008 140  JJ      New                      T3- 
0000008 150  JJ      York-based               Z99 
0000008 160  NN1     Pfizer                   Z99 
0000008 170  VVD     rose                     M1 N5+/A2.1 N3.2+/A2.1 S7.1+/A2.1 
0000008 180  MC      3                        N5[i14.2.1 N1 T1.2 T3 T1.3 N3.2 
0000008 190  NNU     percent                  N5[i14.2.2 N5 
0000008 191  .       .                        
0000009 001  -----   -----                    
0000010 010  AT      The                      Z5 
0000010 020  NN2     companies                I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000010 030  VVD     said                     Q2.1 
0000010 040  PPHS2   they                     Z8mfn 
0000010 050  VBDR    were                     Z5 A3+ 
0000010 060  VVG     reviewing                X2.4/A5 P1 Q4 G3 
0000010 070  AT      the                      Z5 
0000010 080  NN1     Treasury                 Z3c 
0000010 090  NN1     Department               H2/S5+c X2.2 
0000010 091  GE      's                       Z5 
0000010 100  NN1     notice                   Q1.2 Q2.2 I3.1/Q2.2 G2.1/Q1.2 
0000010 101  .       .                        
0000010 102  NULL    <quote>                  
0000010 103  -----   -----                    
0000010 110  II21    Prior                    N4[i15.2.1 
0000010 120  II22    to                       N4[i15.2.2 Z5 
0000010 130  VVG     completing               T2- Q1.2 
0000010 140  DD      any                      N5.1+ N5 
0000010 150  NN1     review                   X2.4 Q4 
0000010 151  ,       ,                        
0000010 160  PPIS2   we                       Z8 
0000010 170  VM      wo                       T1.1.3 
0000010 171  XX      n't                      Z6 
0000010 180  VVI     speculate                X2.6+ I2.1 
0000010 190  II      on                       Z5 
0000010 200  DD      any                      N5.1+ N5 
0000010 210  JJ      potential                A7+ 
0000010 220  NN1     impact                   A2.2 A1.1.1 
0000010 221  ,       ,                        
0000010 222  NULL    </quote>                 
0000010 223  -----   -----                    
0000010 230  AT      the                      Z5 
0000010 240  NN2     companies                I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000010 250  VVD     said                     Q2.1 
0000010 260  II      in                       Z5 
0000010 270  AT1     a                        Z5 
0000010 280  JJ      joint                    S5+ 
0000010 290  NN1     statement                Q2.1 I1/Q1.2 
0000010 291  .       .                        
0000011 001  -----   -----                    
0000012 010  AT      The                      Z5 
0000012 020  JJ      federal                  S5+ 
0000012 030  NN1     government               G1.1c 
0000012 040  VHZ     has                      Z5 A9+ A2.2 S4 
0000012 050  VVN     grappled                 E3- M2 X8+ 
0000012 060  IW      with                     Z5 
0000012 070  AT1     a                        Z5 
0000012 080  NN1     wave                     W3/M4 O4.4 Q1.1 Y1 N5 
0000012 090  IO      of                       Z5 
0000012 100  NN2     inversions               A6.1- 
0000012 110  II      in                       Z5 
0000012 120  JJ      recent                   T3- 
0000012 130  NNT2    years                    T1.3 
0000012 140  CSA     as                       Z5 
0000012 150  NP1     U.S.                     Z8 
0000012 160  NN2     companies                I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000012 170  VH0     have                     Z5 A9+ A2.2 S4 
0000012 180  VVN     sought                   X2.4 
0000012 190  TO      to                       Z5 
0000012 200  VVI     slash                    A1.1.2 N5-/A2.1 
0000012 210  APPGE   their                    Z8 
0000012 220  NN1     tax                      I1.2/I1.1[i16.2.1 I1.1/G1.1 
0000012 230  NN2     bills                    I1.2/I1.1[i16.2.2 I1.3 G1.1 Q1.2 L2 
0000012 240  II      by                       Z5 
0000012 250  VVG     redomiciling             Z99 
0000012 260  RL      overseas                 M6 
0000012 261  ,       ,                        
0000012 270  CS      though                   Z5 
0000012 280  APPGE   their                    Z8 
0000012 290  NN1     core                     O2 F1 A11.1+ Y2% 
0000012 300  NN2     operations               A1.1.1 B3 G3 
0000012 310  CC      and                      Z5 
0000012 320  NN1     management               S7.1+c 
0000012 330  RR      usually                  A6.2+ 
0000012 340  VV0     remain                   T2++ M8 N5.2+ 
0000012 350  II      in                       Z5 
0000012 360  AT      the                      Z5 
0000012 370  NP1     United                   Z2c[i19.2.1 Z2c[i18.2.1 Z3c Z1mf[i17.2.1 Z3c[i17.2.1 
0000012 380  NP1     States                   Z2c[i19.2.2 Z2c[i18.2.2 Z2 Z1mf[i17.2.2 Z3c[i17.2.2 
0000012 390  RR      even                     A13.1 
0000012 400  CSA     as                       Z5 
0000012 410  PPHS2   they                     Z8mfn 
0000012 420  VV0     claim                    Q2.2 A9+ 
0000012 430  AT1     a                        Z5 
0000012 440  JJ      new                      T3- 
0000012 450  NN1     tax                      I1.1/G1.1 
0000012 460  RL      home                     H4 M6 
0000012 461  .       .                        
0000012 462  -----   -----                    
0000012 470  DA2     Several                  N5 
0000012 480  NP1     U.S.                     Z8 
0000012 490  JJ      presidential             G1.1/S7.1+ 
0000012 500  NN2     candidates               G1.2/S2mf I3.1/S2mf P1/S2mf A7+ A1.2+ 
0000012 501  ,       ,                        
0000012 510  II      including                A1.8+ 
0000012 520  NN1     Republican               G1.2/S2mf 
0000012 530  NP1     Donald                   Z1mf[i20.2.1 Z3c[i20.2.1 Z1mf 
0000012 540  NN1     Trump                    Z1mf[i20.2.2 Z3c[i20.2.2 Z1mf 
0000012 550  CC      and                      Z5 
0000012 560  NN1     Democrat                 G1.2/S2mf 
0000012 570  NP1     Hillary                  Z1mf[i21.2.1 Z3c[i21.2.1 
0000012 580  NP1     Clinton                  Z1mf[i21.2.2 Z3c[i21.2.2 Z1mf 
0000012 581  ,       ,                        
0000012 590  VH0     have                     Z5 A9+ A2.2 S4 
0000012 600  VVN     seized                   A9+ X9.2+/G3 S7.1+ 
0000012 610  II      on                       Z5 
0000012 620  AT      the                      Z5 
0000012 630  NN1     issue                    X4.1 Q4.2 S4 A9- 
0000012 640  II      in                       Z5 
0000012 650  APPGE   their                    Z8 
0000012 660  NN2     campaigns                X7+/Q2.2 I2.2/Q2.2 G1.2/Q2.2 G3 
0000012 661  .       .                        
0000013 001  -----   -----                    
0000014 010  NN1     Obama                    Z99 
0000014 011  ,       ,                        
0000014 020  AT1     a                        Z5 
0000014 030  NN1     Democrat                 G1.2/S2mf 
0000014 031  ,       ,                        
0000014 040  VHZ     has                      Z5 A9+ A2.2 S4 
0000014 050  VVN     called                   Q2.2 S1.1.1 Q1.3 S9% 
0000014 060  RR      repeatedly               N6+ 
0000014 070  IF      for                      Z5 
0000014 080  NN1     action                   A1.1.1 G3 
0000014 090  II      by                       Z5 
0000014 100  AT      the                      Z5 
0000014 110  JJ      Republican-controlled    Z99 
0000014 120  NP1     U.S.                     Z1mf[i22.2.1 Z3c[i22.2.1 
0000014 130  NN1     Congress                 Z1mf[i22.2.2 Z3c[i22.2.2 Z3c 
0000014 140  II      on                       Z5 
0000014 150  NN2     inversions               A6.1- 
0000014 151  ,       ,                        
0000014 160  CCB     but                      Z5 
0000014 170  NN2     lawmakers                Z99 
0000014 180  VH0     have                     Z5 A9+ A2.2 S4 
0000014 190  VDN     done                     A1.1.1 G2.2- X9.2+ E3- G2.1% Z5 
0000014 200  DA1     little                   N5- 
0000014 201  .       .                        
0000014 202  -----   -----                    
0000014 210  PPHS1   He                       Z8m 
0000014 220  VVD     repeated                 N6+ Q2.1/N6+ F1/B1@ 
0000014 230  APPGE   his                      Z8m 
0000014 240  NN1     appeal                   Q2.1 O4.2+ G2.1 
0000014 250  II      to                       Z5 
0000014 260  NN1     Congress                 Z2[i23.3.1 Z3c 
0000014 270  II      on                       Z2[i23.3.2 Z5 
0000014 280  NPD1    Monday                   Z2[i23.3.3 T1.3 
0000014 290  CC      and                      Z5 
0000014 300  VVD     said                     Q2.1 
0000014 310  PPHS1   he                       Z8m 
0000014 320  VVD     welcomed                 Q2.2 S1.1.1 
0000014 330  AT      the                      Z5 
0000014 340  NN1     Treasury                 Z3c 
0000014 341  GE      's                       Z5 
0000014 350  NN1     action                   A1.1.1 G3 
0000014 351  .       .                        
0000015 001  -----   -----                    
0000016 010  AT      The                      Z5 
0000016 020  NN1     Treasury                 Z3c 
0000016 030  VVD     said                     Q2.1 
0000016 040  II      in                       Z5 
0000016 050  AT1     a                        Z5 
0000016 060  NN1     statement                Q2.1 I1/Q1.2 
0000016 070  PPH1    it                       Z8 
0000016 080  VM      will                     T1.1.3 
0000016 090  VVI     impose                   S6+ S7.1+/X7- 
0000016 100  AT1     a                        Z5 
0000016 110  JJ      three-year               T1.3 T3 
0000016 120  NN1     limit                    N5.1 A1.7+ M7 
0000016 130  II      on                       Z5 
0000016 140  JJ      foreign                  M7 
0000016 150  NN2     companies                I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000016 160  VVG     bulking                  N5+++ 
0000016 170  RP      up                       Z5 X9.1+ M6 N4 N5++ T2- A1.1.1 N5+/A2.1 
0000016 180  II      on                       Z5 
0000016 190  NP1     U.S.                     Z8 
0000016 200  NN2     assets                   I1.1 A1.5.2+ 
0000016 210  TO      to                       Z5 
0000016 220  VVI     avoid                    A1.9 M1 
0000016 230  NN1     ownership                A9+ 
0000016 240  VVZ     limits                   A1.7+ 
0000016 250  IF      for                      Z5 
0000016 260  AT1     a                        Z5 
0000016 270  JJR     later                    T4-- T1.1.3 N4 
0000016 280  NN1     inversion                A6.1- 
0000016 290  NN1     deal                     N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000016 291  .       .                        
0000018 001  NULL    <quote>                  
0000018 002  -----   -----                    
0000018 010  II      In                       Z5 
0000018 020  JJ      simple                   A12+ A6.2+ O4.1 X9.1- 
0000018 030  NN2     words                    Q3 
0000018 031  ,       ,                        
0000018 040  NP1     Allergan                 Z99 
0000018 041  GE      's                       Z5 
0000018 050  JJ      key                      A11.1+ 
0000018 060  NN2     deals                    N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000018 070  II      in                       Z5 
0000018 080  AT      the                      Z5 
0000018 090  JJ      prior                    N4/T1.1.1 A11.1+ 
0000018 100  MC      36                       N1 T1.2 T3 T1.3 N3.2 
0000018 110  NNT2    months                   T1.3 
0000018 120  VM      wo                       T1.1.3 
0000018 121  XX      n't                      Z6 
0000018 130  VBI     be                       Z5 A3+ 
0000018 140  VVN     counted                  N2 A11.1+ 
0000018 141  (       (                        
0000018 150  CS31    as                       Z5[i24.3.1 Z5 
0000018 160  CS32    far                      Z5[i24.3.2 
0000018 170  CS33    as                       Z5[i24.3.3 Z5 
0000018 180  VVG     meeting                  S3.1 M6 A1.1.1 X9.2+ A6.1+ 
0000018 190  AT      the                      Z5 
0000018 200  NN1     inversion                A6.1- 
0000018 210  NN1     threshold                H2 N5 
0000018 220  VBZ     is                       A3+ Z5 
0000018 230  JJ      concerned                E6- A1.8+ A2.2 S1.1.3+ 
0000018 231  )       )                        
0000018 240  CS      when                     Z5 
0000018 250  VDG     doing                    A1.1.1 G2.2- X9.2+ E3- G2.1% Z5 
0000018 260  AT      the                      Z5 
0000018 270  NN1     ownership                A9+ 
0000018 280  NN1     math                     N2 
0000018 290  IF      for                      Z5 
0000018 300  AT      the                      Z5 
0000018 310  NP1     Pfizer-Allergan          Z99 
0000018 320  NN1     deal                     N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000018 321  ,       ,                        
0000018 322  NULL    </quote>                 
0000018 323  -----   -----                    
0000018 330  VV0     Evercore                 Z99 
0000018 340  NN1     analyst                  Y2/S2mf I2.1/S2mf Y1/S2mf B3/S2mf 
0000018 350  NP1     Umer                     Z1mf[i25.2.1 Z3c[i25.2.1 
0000018 360  NP1     Raffat                   Z1mf[i25.2.2 Z3c[i25.2.2 
0000018 370  VVD     wrote                    Q1.2 I2.1 
0000018 380  II      in                       Z5 
0000018 390  AT1     a                        Z5 
0000018 400  NN1     note                     Q1.2 K2 
0000018 401  .       .                        
0000019 001  -----   -----                    
0000020 010  DD2     These                    Z5 Z8 
0000020 020  NN2     deals                    N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000020 030  VV0     include                  A1.8+ 
0000020 040  AT      the                      Z5 
0000020 050  NNU     $66                      I1.2/Z99[i26.2.1 
0000020 060  NNO     billion                  I1.2/Z99[i26.2.2 N1 I1 
0000020 070  NN1     merger                   S5+ 
0000020 080  IO      of                       Z5 
0000020 090  NP1     Allergan                 Z3[i27.2.1 
0000020 100  NN1     Plc                      Z3[i27.2.2 I2.1/S5+ 
0000020 110  CC      and                      Z5 
0000020 120  NP1     Actavis                  Z3[i28.2.1 
0000020 130  NN1     Plc                      Z3[i28.2.2 I2.1/S5+ 
0000020 131  ,       ,                        
0000020 140  AT      the                      Z5 
0000020 150  NNU     $25                      I1.2/Z99[i29.2.1 
0000020 160  NNO     billion                  I1.2/Z99[i29.2.2 N1 I1 
0000020 170  NN1     purchase                 I2.2 
0000020 180  IO      of                       Z5 
0000020 190  NN1     Forest                   Z3 
0000020 200  NN2     Laboratories             Y1/H1c 
0000020 210  CC      and                      Z5 
0000020 220  AT      the                      Z5 
0000020 230  NNU     $5                       I1.2/Z99[i30.2.1 
0000020 240  NNO     billion                  I1.2/Z99[i30.2.2 N1 I1 
0000020 250  NN1     takeover                 S7.1+ 
0000020 260  IO      of                       Z5 
0000020 270  NP1     Warner                   Z1mf[i31.2.1 Z3c[i31.2.1 Z1mf Z3c 
0000020 280  NP1     Chilcott                 Z1mf[i31.2.2 Z3c[i31.2.2 
0000020 281  .       .                        
0000022 001  NULL    <quote>                  
0000022 002  -----   -----                    
0000022 010  AT      The                      Z5 
0000022 020  JJ      real                     A3+ A5.2+ A5.4+ A13.3 
0000022 030  NN1     issue                    X4.1 Q4.2 S4 A9- 
0000022 040  VBZ     is                       A3+ Z5 
0000022 050  XX      not                      Z6 
0000022 060  RG      so                       A13.3 
0000022 070  RR      much                     A13.3 N6+ 
0000022 080  DDQ     what                     Z5 Z8 
0000022 090  NP1     Allergan                 Z99 
0000022 100  VM      may                      A7+ 
0000022 110  VVI     prove                    A5.2+ X2.4 
0000022 120  CC      or                       Z5 
0000022 130  VVI     disprove                 A5.2- 
0000022 131  ,       ,                        
0000022 140  CC      or                       Z5 
0000022 150  CSW     whether                  Z5 
0000022 160  NN1     Treasury                 Z3c 
0000022 170  VVD     overstepped              N5.2+ 
0000022 180  APPGE   its                      Z8 
0000022 190  NN1     authority                G1.1c S7.1+ S7.4+ X2.2+ 
0000022 191  .       .                        
0000022 192  -----   -----                    
0000022 200  AT      The                      Z5 
0000022 210  JJ      real                     A3+ A5.2+ A5.4+ A13.3 
0000022 220  NN1     question                 Q2.2 X4.1 
0000022 230  VBZ     is                       A3+ Z5 
0000022 240  CSW     whether                  Z5 
0000022 250  NP1     Pfizer                   Z99 
0000022 260  VVZ     reads                    Q3 Q1.2 X3.2+ X2.5+ P1 A10+ 
0000022 270  RT      today                    T1.1.2 
0000022 271  GE      's                       Z5 
0000022 280  NN2     regulations              G2.1 A1.7+/G1.1 
0000022 290  CSA     as                       Z5 
0000022 300  NN1     reason                   A2.2 X2.1 
0000022 310  RR      enough                   N5+ N6+ 
0000022 320  TO      to                       Z5 
0000022 330  XX      not                      Z6 
0000022 340  VVI     continue                 T2++ 
0000022 350  TO      to                       Z5 
0000022 360  VVI     pursue                   A1.1.1 X8+ X2.4 M1 
0000022 370  AT      the                      Z5 
0000022 380  NN1     deal                     N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000022 381  ,       ,                        
0000022 382  NULL    </quote>                 
0000022 383  -----   -----                    
0000022 390  NP1@    Raffat                   Z99 
0000022 400  VVD     wrote                    Q1.2 I2.1 
0000022 401  .       .                        
0000023 001  -----   -----                    
0000024 010  II      Under                    Z5 
0000024 020  AT      the                      Z5 
0000024 030  NN1     agreement                A6.1+ Q2.2 
0000024 040  II      between                  Z5 
0000024 050  NP1     Pfizer                   Z99 
0000024 060  CC      and                      Z5 
0000024 070  NP1     Allergan                 Z99 
0000024 071  ,       ,                        
0000024 080  DD1     either                   Z5 Z8 
0000024 090  NN1     party                    K1/S1.1.3+c G1.2c S1.1.3+/S2mf S5+c 
0000024 100  VM      may                      A7+ 
0000024 110  VVI     terminate                T2- 
0000024 120  AT      the                      Z5 
0000024 130  NN1     deal                     N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000024 140  CS      if                       Z7 
0000024 150  AT1     an                       Z5 
0000024 160  JJ      adverse                  S8- 
0000024 170  NN1     change                   A2.1+ I1 B1 
0000024 180  II      in                       Z5 
0000024 190  NP1     U.S.                     Z8 
0000024 200  NN1     law                      G2.1 S6+ Y1 
0000024 210  VM      would                    A7+ 
0000024 220  VVI     cause                    A2.2 
0000024 230  AT      the                      Z5 
0000024 240  JJ      combined                 A2.2 A1.8+ S5+c F4 
0000024 250  NN1     company                  I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000024 260  TO      to                       Z5 
0000024 270  VBI     be                       Z5 A3+ 
0000024 280  VVN     treated                  S1.1.1 A9- X4.2 X2.1 B3 A1.1.1 
0000024 290  II      as                       Z5 
0000024 300  AT1     a                        Z5 
0000024 310  NP1     U.S.                     Z8 
0000024 320  JJ      domestic                 H4 S4 E3+/L2 M6 
0000024 330  NN1     corporation              I2.1/S5c G1.1c 
0000024 340  IF      for                      Z5 
0000024 350  JJ      federal                  S5+ 
0000024 360  NN1     income                   G1.1/I1.2[i32.2.1 I1.1 G1.1/I1[i33.2.1 
0000024 370  NN1     tax                      G1.1/I1.2[i32.2.2 I1.1/G1.1 G1.1/I1[i33.2.2 
0000024 380  NN2     purposes                 X7+ A2.2 A1.5.1 
0000024 381  .       .                        
0000024 382  -----   -----                    
0000024 390  AT      The                      Z5 
0000024 400  JJ      terminating              T2- 
0000024 410  NN1     party                    K1/S1.1.3+c G1.2c S1.1.3+/S2mf S5+c 
0000024 420  VM      would                    A7+ 
0000024 430  VHI     have                     S6+[i34.2.1 A9+ Z5 A2.2 S4 
0000024 440  TO      to                       S6+[i34.2.2 Z5 
0000024 450  VVI     pay                      I1.2 A9- I1.1/I3.1 
0000024 460  AT      the                      Z5 
0000024 470  JJ      other                    A6.1- 
0000024 480  NN1     company                  I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000024 490  RG21    up                       Z5 X9.1+ M6 N4 N5++ T2- A1.1.1 N5+/A2.1 
0000024 500  RG22    to                       Z5 M6 
0000024 510  NNU     $400                     Z99/H1c[i35.2.1 
0000024 520  NNO     million                  Z99/H1c[i35.2.2 N1 I1 
0000024 530  IF      for                      Z5 
0000024 540  APPGE   its                      Z8 
0000024 550  NN2     expenses                 I1.3 
0000024 551  ,       ,                        
0000024 560  II21    according                Z5[i36.2.1 Z5 
0000024 570  II22    to                       Z5[i36.2.2 Z5 
0000024 580  AT      the                      Z5 
0000024 590  NN1     merger                   S5+ 
0000024 600  NN1     agreement                A6.1+ Q2.2 
0000024 601  .       .                        
0000025 001  -----   -----                    
0000026 010  NP1     LEW                      Z99 
0000026 020  VVZ     SAYS                     Q2.1 
0000026 030  NN1     LEGISLATION              G2.1 
0000026 040  RR      STILL                    T2++ Z4 E3+ 
0000026 050  VVN     NEEDED                   S6+ 
0000028 010  NN1     Treasury                 Z3c 
0000028 020  RR      also                     N5++ 
0000028 030  VVD     said                     Q2.1 
0000028 040  PPH1    it                       Z8 
0000028 050  VBZ     is                       Z5 A3+ 
0000028 060  VVG     proposing                Q2.2/X7+ X4.1 G1.2 Q2.2/S4 
0000028 070  NN2     rules                    G2.1 X4.2 A6.2+ Q3 
0000028 080  TO      to                       Z5 
0000028 090  VVI     tackle                   A1.1.1 K5.1 Q2.2 
0000028 100  AT1     a                        Z5 
0000028 110  NN1     practice                 A1.1.1 I3.1/S5+c 
0000028 120  VVN     known                    X2.2+ S3.2/B1% 
0000028 130  II      as                       Z5 
0000028 140  NN2     earnings                 I1.1 
0000028 150  VVG     stripping                B5- A1.1.1 A9- 
0000028 160  DD1     that                     Z8 Z5 
0000028 170  VBZ     is                       Z5 A3+ 
0000028 180  RR      often                    N6+ 
0000028 190  VVN     undertaken               A1.1.1 Q2.2 
0000028 200  II@     following                Z5 
0000028 210  AT1     an                       Z5 
0000028 220  NN1     inversion                A6.1- 
0000028 221  .       .                        
0000029 001  -----   -----                    
0000030 010  NN2     Earnings                 I1.1 
0000030 020  VVG     stripping                B5- A1.1.1 A9- 
0000030 030  VVZ     covers                   A10- M1 N3.6 S8+ I1.1 A1.8+ N5 Q2.1 A1.1.1 
0000030 040  AT1     a                        Z5 
0000030 050  NN1     range                    N3.3 K2 A6.3+ N5 A4.1 M7/K5.1 M7/G3 N2 W3 F1/O2 
0000030 060  IO      of                       Z5 
0000030 070  JJ      financial                I1 
0000030 080  NN2     dealings                 A1.1.1 
0000030 090  CST     that                     Z8 Z5 
0000030 100  VV0     shrink                   N3.2-/A2.1 E2-@ 
0000030 110  AT      the                      Z5 
0000030 120  JJ      taxable                  I1.1/G1.1 
0000030 130  NP1     U.S.                     Z8 
0000030 140  NN2     profits                  I1.1 A5.1+ 
0000030 150  IO      of                       Z5 
0000030 160  NN2     multinationals           M7/S5 
0000030 161  .       .                        
0000030 162  -----   -----                    
0000030 170  AT1     A                        Z5 
0000030 180  JJ      common                   A6.2+ N5++ S5+ O4.2- 
0000030 190  NN1     strategy                 X7+ 
0000030 200  VBZ     is                       A3+ Z5 
0000030 210  TO      to                       Z5 
0000030 220  VVI     load                     M2[i37.2.1 G3[i37.2.1 M2 G3 
0000030 230  RP      up                       M2[i37.2.2 G3[i37.2.2 
0000030 240  AT      the                      Z5 
0000030 250  NP1     U.S.                     Z8 
0000030 260  NN1     unit                     S5+c O2 H5 H1 N3.1 P1 N1 
0000030 270  IO      of                       Z5 
0000030 280  AT1     a                        Z5 
0000030 290  JJ@     redomiciled              Z99 
0000030 300  JJ      foreign                  M7 
0000030 310  NN1     company                  I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000030 320  IW      with                     Z5 
0000030 330  NN1     debt                     I1.2 
0000030 340  CC      and                      Z5 
0000030 350  RT      then                     N4 Z5 T1.2 
0000030 360  VV0     shift                    M2 M1 A2.1+ I2.2 
0000030 370  NP1     U.S.                     Z8 
0000030 380  NN2     profits                  I1.1 A5.1+ 
0000030 390  II      to                       Z5 
0000030 400  AT      the                      Z5 
0000030 410  JJ      new                      T3- 
0000030 420  JJ      lower-tax                Z99 
0000030 430  JJ      foreign                  M7 
0000030 440  NN1     jurisdiction             S7.1+ 
0000030 450  II      through                  Z5 
0000030 460  NN1     interest                 X5.2+ I1.1 S8+ S1.1.3+ 
0000030 470  NN2     payments                 I1.1 
0000030 471  .       .                        
0000031 001  -----   -----                    
0000032 010  AT      The                      Z5 
0000032 020  JJ      new                      T3- 
0000032 030  NN1     Treasury                 Z3c 
0000032 040  NN2     rules                    G2.1 X4.2 A6.2+ Q3 
0000032 050  VM      would                    A7+ 
0000032 060  VVI     restrict                 A1.7+ 
0000032 070  JJ      related-party            Z99 
0000032 080  NN1     debt                     I1.2 
0000032 090  IF      for                      Z5 
0000032 100  NP1     U.S.                     Z8 
0000032 110  NN2     subsidiaries             A11.1- S5+ 
0000032 120  II      in                       Z5 
0000032 130  NN2     dealings                 A1.1.1 
0000032 140  CST     that                     Z8 Z5 
0000032 150  VD0     do                       Z5 A1.1.1 G2.2- X9.2+ E3- N5+ G2.1% 
0000032 160  XX      not                      Z6 
0000032 170  VVI     finance                  I1 
0000032 180  JJ      new                      T3- 
0000032 190  NN1     investment               I1.1 
0000032 200  II      in                       Z5 
0000032 210  AT      the                      Z5 
0000032 220  NP1     United                   Z2c[i40.2.1 Z2c[i39.2.1 Z3c Z1mf[i38.2.1 Z3c[i38.2.1 
0000032 230  NP1     States                   Z2c[i40.2.2 Z2c[i39.2.2 Z2 Z1mf[i38.2.2 Z3c[i38.2.2 
0000032 231  .       .                        
0000032 232  -----   -----                    
0000032 240  II      As                       Z5 
0000032 250  NN1     part                     N5.1- O2 M7 I3.1 S1.1.3+ K4 
0000032 260  IO      of                       Z5 
0000032 270  DD2     these                    Z5 Z8 
0000032 280  JJ      proposed                 Q2.2/X7+ X4.1 G1.2 Q2.2/S4 
0000032 290  NN2     regulations              G2.1 A1.7+/G1.1 
0000032 291  ,       ,                        
0000032 300  AT      the                      Z5 
0000032 310  JJ      Internal                 M6 A10- G1.1 
0000032 320  NN1     Revenue                  G1.1/I1 I1.1+ Z3c 
0000032 330  NN1     Service                  S8+ S7.1- I2.2 A1.1.1 S9 I3.1 F1 G3@ G1.1@ G2.1@ 
0000032 340  VM      would                    A7+ 
0000032 350  RR      also                     N5++ 
0000032 360  VBI     be                       A3+ Z5 
0000032 370  JK      able                     X9.1+ 
0000032 380  TO      to                       Z5 
0000032 390  VVI     divide                   A6.1- A9-/N5.1 N2 
0000032 400  NN1     debt                     I1.2 
0000032 410  NN2     instruments              O2 K2 X4.2 B3 Y1 
0000032 420  II      into                     Z5 
0000032 430  NN1     part                     N5.1- O2 M7 I3.1 S1.1.3+ K4 
0000032 440  NN1     debt                     I1.2 
0000032 450  CC      and                      Z5 
0000032 460  NN1     part                     N5.1- O2 M7 I3.1 S1.1.3+ K4 
0000032 470  NN1     equity                   G2.2+ G2.1 I1.1 
0000032 471  ,       ,                        
0000032 480  NN1     Treasury                 Z3c 
0000032 490  VVD     said                     Q2.1 
0000032 491  .       .                        
0000033 001  -----   -----                    
0000034 010  NN1     Treasury                 G1.1/I1.1c 
0000034 020  NN1     Secretary                I3.2/S2mf S7.1+/S2mf 
0000034 030  NP1     Jack                     Z1mf[i41.2.1 Z3c[i41.2.1 Z1m 
0000034 040  NP1     Lew                      Z1mf[i41.2.2 Z3c[i41.2.2 
0000034 050  VVD     said                     Q2.1 
0000034 060  AT      the                      Z5 
0000034 070  JJ      new                      T3- 
0000034 080  NN2     actions                  A1.1.1 G3 
0000034 090  VM      would                    A7+ 
0000034 091  NULL    <quote>                  
0000034 092  -----   -----                    
0000034 100  RRR     further                  N5++ N3.3++ T2++ 
0000034 110  VV0     rein                     O2 A1.7+ S7.1+ 
0000034 120  RP@     in                       M6 
0000034 121  NULL    </quote>                 
0000034 122  -----   -----                    
0000034 130  NN2     inversions               A6.1- 
0000034 131  ,       ,                        
0000034 140  CS      while                    Z5 
0000034 150  PPHS1   he                       Z8m 
0000034 160  VVD     repeated                 N6+ Q2.1/N6+ F1/B1@ 
0000034 170  APPGE   his                      Z8m 
0000034 180  NN1     call                     Q2.2 S1.1.1 Q1.3 X7+ S9% 
0000034 190  CST     that                     Z5 Z8 
0000034 200  JJ      only                     A14 
0000034 210  NN1     legislation              G2.1 
0000034 220  II      in                       Z5 
0000034 230  NN1     Congress                 Z3c 
0000034 240  VM      could                    A7+ 
0000034 250  VVI     prevent                  S8- 
0000034 260  DA      such                     Z5 Z8 
0000034 270  NN2     deals                    N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000034 271  .       .                        
0000035 001  -----   -----                    
0000036 010  CCB     But                      Z5 
0000036 020  RR21    at                       A13.7[i42.2.1 
0000036 030  RR22    least                    A13.7[i42.2.2 A13.7 
0000036 040  MC1     one                      N1 T3 T1.2 
0000036 050  NN1     business                 I2.1 A1.1.1 A5.1+++ 
0000036 060  NN1     group                    S5+c A4.1c B3% 
0000036 061  ,       ,                        
0000036 070  AT      the                      Z5 
0000036 080  NN1     Organization             S5+c S7.1+ 
0000036 090  IF      for                      Z5 
0000036 100  JJ      International            M7 
0000036 110  NN1     Investment               I1.1 
0000036 111  ,       ,                        
0000036 120  DDQ     which                    Z5 Z8 
0000036 130  NN2     advocates                Q2.2/S2mf G2.1/S2mf 
0000036 140  IF      for                      Z5 
0000036 150  JJ      foreign-based            Z99 
0000036 160  NN2     companies                I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000036 161  ,       ,                        
0000036 170  VVD     condemned                Q2.2/E2- Q2.2/A1.1.2 G2.1 
0000036 180  AT      the                      Z5 
0000036 190  JJ      new                      T3- 
0000036 200  NN2     rules                    G2.1 X4.2 A6.2+ Q3 
0000036 201  .       .                        
0000038 001  NULL    <quote>                  
0000038 002  -----   -----                    
0000038 010  NN1     Treasury                 G1.1/I1.1c 
0000038 011  GE      's                       Z5 
0000038 020  NN1     action                   A1.1.1 G3 
0000038 030  VM      would                    A7+ 
0000038 040  VVI     increase                 N5+/A2.1 
0000038 050  AT      the                      Z5 
0000038 060  NN1     cost                     I1.3 
0000038 070  IO      of                       Z5 
0000038 080  JJ      investing                I1 
0000038 090  CC      and                      Z5 
0000038 100  VVG     expanding                N3.2+/A2.1 Q2.2/N5++ A4.2-/A2.1 
0000038 110  II      across                   Z5 
0000038 120  AT      the                      Z5 
0000038 130  NP1     United                   Z2c[i45.2.1 Z2c[i44.2.1 Z3c Z1mf[i43.2.1 Z3c[i43.2.1 
0000038 140  NP1     States                   Z2c[i45.2.2 Z2c[i44.2.2 Z2 Z1mf[i43.2.2 Z3c[i43.2.2 
0000038 150  IF      for                      Z5 
0000038 160  DB      all                      N5.1+ 
0000038 170  JJ      foreign                  M7 
0000038 180  NN2     companies                I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000038 190  CC      and                      Z5 
0000038 200  VVN     put                      M2 Q2.1 Q2.2 A1.1.1 
0000038 210  II      at                       A15-[i46.2.1 Z5 
0000038 220  NN1     risk                     A15-[i46.2.2 A15- A1.4 
0000038 230  DAR     more                     N5++ 
0000038 240  CSN     than                     Z5 
0000038 250  MC      12                       N1[i47.2.1 T1.3[i47.2.1 I1[i47.2.1 N1 T1.2 T3 T1.3 N3.2 
0000038 260  NNO     million                  N1[i47.2.2 T1.3[i47.2.2 I1[i47.2.2 N1 I1 
0000038 270  JJ      American                 Z2 
0000038 280  NN2     workers                  I3.1/S2mf 
0000038 290  CST     that                     Z8 Z5 
0000038 300  VBR     are                      Z5 A3+ 
0000038 310  VVN     supported                S8+ A1.1.1 K5.1 I1.1 A10+ 
0000038 320  II      by                       Z5 
0000038 330  JJ      foreign                  M7 
0000038 340  JJ      direct                   M6 O4.4 N3.8+ S1.2 A10+ S1.1.1 
0000038 350  NN1     investment               I1.1 
0000038 360  II      in                       Z5 
0000038 370  AT      the                      Z5 
0000038 380  NP1     United                   Z2c[i50.2.1 Z2c[i49.2.1 Z3c Z1mf[i48.2.1 Z3c[i48.2.1 
0000038 390  NP1     States                   Z2c[i50.2.2 Z2c[i49.2.2 Z2 Z1mf[i48.2.2 Z3c[i48.2.2 
0000038 391  ,       ,                        
0000038 392  NULL    </quote>                 
0000038 393  -----   -----                    
0000038 400  NP1     Nancy                    Z1mf[i51.2.1 Z3c[i51.2.1 Z1f Z2 
0000038 410  NP1     McLemon                  Z1mf[i51.2.2 Z3c[i51.2.2 
0000038 411  ,       ,                        
0000038 420  AT      the                      Z5 
0000038 430  NN1     group                    S5+c A4.1c B3% 
0000038 431  GE      's                       Z5 
0000038 440  JJ      chief                    S7.1+/S2mf[i52.2.1 S7.1+ 
0000038 450  NN1     executive                S7.1+/S2mf[i52.2.2 
0000038 451  ,       ,                        
0000038 460  VVD     said                     Q2.1 
0000038 470  II      in                       Z5 
0000038 480  AT1     a                        Z5 
0000038 490  NN1     statement                Q2.1 I1/Q1.2 
0000038 491  .       .                        
0000039 001  -----   -----                    
0000040 010  DA      Such                     Z5 Z8 
0000040 020  NN1     tax                      I1.1/G1.1 
0000040 030  NN1     avoidance                A1.9 
0000040 040  NN2     schemes                  X7+ X4.2 
0000040 050  VH0     have                     Z5 A9+ A2.2 S4 
0000040 060  RR      long                     T1.3+ 
0000040 070  VBN     been                     A3+ Z5 
0000040 080  AT1     a                        Z5 
0000040 090  NN1     thorn                    L3 
0000040 100  II      in                       Z5 
0000040 110  NN1     Treasury                 Z3c 
0000040 111  GE      's                       Z5 
0000040 120  NN1     side                     A4.1 M6 N5.1- S7.3+/S5+c B1 S5+c S4c F1 S1.2 
0000040 121  .       .                        
0000040 122  -----   -----                    
0000040 130  AT      The                      Z5 
0000040 140  JJ      proposed                 Q2.2/X7+ X4.1 G1.2 Q2.2/S4 
0000040 150  NN1     deal                     N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000040 160  II      between                  Z5 
0000040 170  NP1     Pfizer                   Z99 
0000040 180  CC      and                      Z5 
0000040 190  NP1     Allergan                 Z99 
0000040 191  ,       ,                        
0000040 200  DDQ     which                    Z8 Z5 
0000040 210  VM      would                    A7+ 
0000040 220  VVI     create                   A1.1.1 A2.2 E1 
0000040 230  AT      the                      Z5 
0000040 240  NN1     world                    W1 S5+c A4.1 N5+ 
0000040 241  GE      's                       Z5 
0000040 250  JJT     largest                  N3.2+++ N5+++ A11.1+++ 
0000040 260  NN1     drugmaker                Z99 
0000040 261  ,       ,                        
0000040 270  VVD     prompted                 A2.2 K4/Q2.2 Q2.2 
0000040 280  JJ      renewed                  T2+/A2.1 
0000040 290  NN1     scrutiny                 X2.4 
0000040 291  .       .                        
0000041 001  -----   -----                    
0000042 010  NN1     Pfizer                   Z99 
0000042 020  VVZ     plans                    X7+ 
0000042 030  II      to                       Z5 
0000042 040  NN1     redomicile               Z99 
0000042 050  II      in                       Z5 
0000042 060  NP1     Ireland                  Z2 Z1mf 
0000042 061  ,       ,                        
0000042 070  RRQ     where                    M6 
0000042 080  NP1     Allergan                 Z99 
0000042 090  VBZ     is                       Z5 A3+ 
0000042 100  VVN     based                    T2+ M6 A2.2 
0000042 101  ,       ,                        
0000042 110  CC      and                      Z5 
0000042 120  AT      the                      Z5 
0000042 130  NN2     companies                I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000042 140  VV0     expect                   X2.6+ B1 
0000042 150  TO      to                       Z5 
0000042 160  VVI     complete                 T2- Q1.2 
0000042 170  APPGE   their                    Z8 
0000042 180  NN1     merger                   S5+ 
0000042 190  II      in                       Z5 
0000042 200  AT      the                      Z5 
0000042 210  MD      second                   N4 
0000042 220  NN1     half                     N5 N5c N1 A13.4 
0000042 230  IO      of                       Z5 
0000042 240  DD1     this                     M6 Z5 Z8 
0000042 250  NNT1    year                     T1.3 P1c 
0000042 251  .       .                        
0000043 001  -----   -----                    
0000044 010  MD      Last                     T1.1.1[i54.2.1 N4 T1.3[i53.2.1 
0000044 020  NPM1    November                 T1.1.1[i54.2.2 T1.3 T1.3[i53.2.2 
0000044 021  ,       ,                        
0000044 030  VVG     following                M1 N4 S7.1- X2.4 X2.5+ A6.1+ A1.1.1 A2.2 K5.1 X3.4 
0000044 040  AT      the                      Z5 
0000044 050  NN1     announcement             Q2.2 
0000044 060  IO      of                       Z5 
0000044 070  AT      the                      Z5 
0000044 080  NP1     Allergan-Pfizer          Z99 
0000044 090  NN1     deal                     N5 Q2.2 A1.1.1 I2.2 K5.2 F3/I2.2 
0000044 091  ,       ,                        
0000044 100  NN1     Treasury                 Z3c 
0000044 110  VVD     clamped                  A1.7+[i55.2.1 A1.7+ G2.1 
0000044 120  RP      down                     A1.7+[i55.2.2 
0000044 130  II      on                       Z5 
0000044 140  NN2     inversions               A6.1- 
0000044 150  II      by                       Z5 
0000044 160  VVG     limiting                 A1.7+ 
0000044 170  AT1     a                        Z5 
0000044 180  NP1     U.S.                     Z8 
0000044 190  NN1     acquirer                 A9+ A9+/S2mf 
0000044 191  GE      's                       Z5 
0000044 200  NN1     ability                  X9.1+ 
0000044 210  TO      to                       Z5 
0000044 220  VVI     set                      T2+[i56.2.1 S7.1+[i56.2.1 O2[i56.2.1 A1.1.1[i56.2.1 M2 M6 O4.5 O4.1 W4 A1.1.1 B3 B4 X6+ S6+ K2 Q4.3 
0000044 230  RP      up                       T2+[i56.2.2 S7.1+[i56.2.2 O2[i56.2.2 A1.1.1[i56.2.2 
0000044 240  AT1     a                        Z5 
0000044 250  JJ      new                      T3- 
0000044 260  JJ      foreign                  M7 
0000044 270  NN1     parent                   S4mf A9+ 
0000044 280  II      in                       Z5 
0000044 290  AT1     a                        Z5 
0000044 300  MD      third                    N4 N5 N1 
0000044 310  NN1     country                  G1.1c W3 F4/M7 K2 
0000044 320  CC      and                      Z5 
0000044 330  II      to                       Z5 
0000044 331  NULL    <quote>                  
0000044 332  -----   -----                    
0000044 340  NN1     stuff                    O1 O2 
0000044 341  NULL    </quote>                 
0000044 342  -----   -----                    
0000044 350  NN2     assets                   I1.1 A1.5.2+ 
0000044 360  II      into                     Z5 
0000044 370  AT1     a                        Z5 
0000044 380  JJ      foreign                  M7 
0000044 390  NN1     parent                   S4mf A9+ 
0000044 400  TO      to                       Z5 
0000044 410  VVI     meet                     S3.1 M6 A1.1.1 X9.2+ A6.1+ 
0000044 420  JJ      post-inversion           Z99 
0000044 430  NN1     ownership                A9+ 
0000044 440  NN2     limits                   N5.1 A1.7+ M7 
0000044 441  .       .                        
0000045 001  -----   -----                    
0000046 010  II      On                       Z5 
0000046 020  NN1     Treasury                 Z3c 
0000046 021  GE      's                       Z5 
0000046 030  JJT     latest                   T3--- T4--- 
0000046 040  NN2     steps                    M1 T1.2 H5 A1.1.1 K1@ 
0000046 041  ,       ,                        
0000046 050  NNB     Senator                  G1.2/S2mf 
0000046 060  NP1     Charles                  Z1m 
0000046 070  NN1     Schumer                  Z99 
0000046 080  IO      of                       Z5 
0000046 090  NP1     New                      Z2[i58.2.1 Z1mf[i57.2.1 Z3c[i57.2.1 
0000046 100  NP1     York                     Z2[i58.2.2 Z2 Z1mf Z1mf[i57.2.2 Z3c[i57.2.2 
0000046 101  ,       ,                        
0000046 110  PNQS    who                      Z8 
0000046 120  VHZ     has                      Z5 A9+ A2.2 S4 
0000046 130  VBN     been                     A3+ Z5 
0000046 140  AT1     a                        Z5 
0000046 150  NN1     co-sponsor               Z99 
0000046 160  IO      of                       Z5 
0000046 170  NN1     legislation              G2.1 
0000046 180  TO      to                       Z5 
0000046 190  VVI     curb                     A1.7+ 
0000046 200  NN2     inversions               A6.1- 
0000046 201  ,       ,                        
0000046 210  VVD     said                     Q2.1 
0000046 220  II      in                       Z5 
0000046 230  AT1     a                        Z5 
0000046 240  NN1     statement                Q2.1 I1/Q1.2 
0000046 241  :       :                        
0000046 242  NULL    <quote>                  
0000046 243  -----   -----                    
0000046 250  DD2     These                    Z5 Z8 
0000046 260  NN2     regulations              G2.1 A1.7+/G1.1 
0000046 270  VM      will                     T1.1.3 
0000046 280  VVI     make                     A1.1.1 A9+ A2.2 S6+ A3+ A9- X9.2+ X6+ 
0000046 290  JJ      potential                A7+ 
0000046 300  NN2     inverters                Z99 
0000046 310  CC      and                      Z5 
0000046 320  JJ      foreign                  M7 
0000046 330  NN2     acquirers                A9+ A9+/S2mf 
0000046 340  VV0     think                    A7-[i59.2.1 X2.1 
0000046 350  RR      twice                    A7-[i59.2.2 N6 
0000046 360  II      before                   Z5 
0000046 370  VVG     making                   A1.1.1 A9+ A2.2 S6+ A3+ A9- X9.2+ X6+ 
0000046 380  AT      the                      Z5 
0000046 390  NN1     leap                     M1 N5+/A2.1 
0000046 391  ,       ,                        
0000046 400  CC      and                      Z5 
0000046 410  DD2     those                    Z5 Z8 
0000046 420  JJ      bad                      A5.1- G2.2- O4.2- B2- 
0000046 430  NN2     actors                   K4/S2.2m A1.1.1/S2mf@ 
0000046 440  VM      should                   S6+ A7+ 
0000046 450  VBI     be                       A3+ Z5 
0000046 460  II      on                       Z5 
0000046 470  NN1     notice                   Q1.2 Q2.2 I3.1/Q2.2 G2.1/Q1.2 
0000046 480  CST     that                     Z8 Z5 
0000046 490  PPIS2   we                       Z8 
0000046 500  VV0     intend                   X7+ 
0000046 510  TO      to                       Z5 
0000046 520  VVI     clamp                    A1.7+[i60.2.1 A1.7+ G2.1 
0000046 530  RP      down                     A1.7+[i60.2.2 
0000046 540  RR      even                     A13.1 
0000046 550  RRR     further                  N5++ N3.3++ T2++ 
0000046 551  .       .                        
0000046 552  NULL    </quote>                 
0000046 553  -----   -----                    
0000048 001  (       (                        
0000048 010  DD1     This                     M6 Z5 Z8 
0000048 020  NN1     story                    Q2.1 X4.1 Q4 
0000048 030  VHZ     has                      Z5 A9+ A2.2 S4 
0000048 040  VBN     been                     Z5 A3+ 
0000048 050  VVN@    refiled                  Z99 
0000048 060  TO      to                       Z5 
0000048 070  VVI     correct                  A5.3+/A2.1 
0000048 080  NN1     syntax                   Q3 
0000048 090  II      in                       Z5 
0000048 100  NN1     headline                 Q4.2 
0000048 101  .       .                        
0000048 102  -----   -----                    
0000048 110  PPH1    It                       Z8 
0000048 120  VBDZ    was                      Z5 A3+ 
0000048 130  RRR     earlier                  N4 T1.1.1 T4++ 
0000048 140  VVN     refiled                  Z99 
0000048 150  TO      to                       Z5 
0000048 160  VVI     add                      N5+/A2.1 N2 A1.8+ 
0000048 170  JJ%     dropped                  M2 M1 N5-/A2.1 O1.2/M1 B2- T2- A9- A1.8- X9.2-/K5 X3.2 
0000048 180  NN1     word                     Q3 Q2.1 S9@ 
0000048 181  NULL    <quote>                  
0000048 182  -----   -----                    
0000048 190  NN1     Pfizer                   Z99 
0000048 191  NULL    </quote>                 
0000048 192  -----   -----                    
0000048 200  II      in                       Z5 
0000048 210  NN1     paragraph                Q3 
0000048 220  MC      3                        N1 T1.2 T3 T1.3 N3.2 
0000048 221  )       )                        
0000051 001  NULL    **8;7;text               
